Chester County News and Community Website
TELA Bio, Inc. (Nasdaq: TELA), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction.
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced its participation in Piper Sandler’s 36th Annual Healthcare Conference, a premier event showcasing leading innovations in the healthcare sector.
TELA Bio Set to Unveil Innovations at Piper Sandler’s Premier Healthcare Conference! Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has announced impressive financial results for the third quarter of 2024, achieving a record revenue of $19.0 million. This marks a robust …
TELA Bio Reports Strong Revenue Growth in Q3 2024 Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has announced the recent approval of inducement grants consisting of restricted stock units (RSUs) to six newly hired employees. The Compensation Committee …
TELA Bio Announces Inducement Grants of Restricted Stock Units to New Employees Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) is set to announce its third-quarter 2024 financial results on Thursday, November 7, 2024. The management team will host a conference call …
Get Ready: TELA Bio to Unveil Q3 2024 Financial Results on November 7! Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has reported its financial results for the second quarter ended June 30, 2024. The company showcased notable revenue growth and significant strategic …
TELA Bio Announces Second Quarter 2024 Financial Results and Strategic Developments Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) recently approved inducement grants of restricted stock units for nine newly-hired employees. The grants cover 16,000 shares of common stock and have …
TELA Bio Announces Inducement Grants for New Employees Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced its participation in the Canaccord Genuity 44th Annual Growth Conference. Scheduled to present on August 14th, 2024, at 10:30 am ET, …
TELA Bio to Present at Canaccord Genuity’s Growth Conference Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) will report its second quarter 2024 financial results on Monday, August 12, 2024. The company’s management team will hold a conference call …
TELA Bio to Announce Second Quarter 2024 Financial Results Read More MALVERN, PA — TELA Bio, Inc. (Nasdaq: TELA) announced the appointment of Jeffrey Blizard, Global Head of Surgical Sales at Abiomed, to its Board of Directors. This move, effective June …
TELA Bio Appoints Jeffrey Blizard to Board, Strengthening Sales Expertise Read More MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced the appointment of Greg Firestone as the company’s new Chief Commercial Officer. Firestone will oversee commercial operations, including key product launches, …
TELA Bio Appoints Greg Firestone as Chief Commercial Officer Read More